Domov › Rakovina prostaty › Massachusetts
Klinické štúdie Rakovina prostaty v štáte Massachusetts
66 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Massachusetts.
Mestá v štáte Massachusetts
Oficiálny text štúdie (anglicky)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Dana-Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Massachusetts General Hospital, Boston
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Dana-Farber Cancer Institute at Foxborough, Foxborough
- Dana Farber-Merrimack Valley, Methuen
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford
- a 2 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lahey Clinic, Burlington
- Lahey Clinic Peabody, Peabody
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Massachusetts General Hospital, Boston
Prebieha náborFáza 4
Vek 18 a viac · Muži · Aktualizované 29. 9. 2026 · NCT07569926Precision-Based Genomics in Prostate Cancer
- Dana Farber Cancer Institute, Boston, MA, Boston
Prebieha náborObservačná štúdia
Vek 18 až 120 · Muži · Aktualizované 28. 9. 2026 · NCT04706663Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Dana Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 28. 9. 2026 · NCT06496256A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Greater Boston Urology, Plymouth
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT07832292Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Boston
Prebieha náborFáza 1/2
Vek 18 až 130 · Muži · Aktualizované 25. 9. 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Dana Farber Mass General Brigham Cancer Care Inc, Boston
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Harvard Medical School-Massachusetts General Hospital, Boston
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT06801236Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
- Dana-Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT07729150A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 24. 9. 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
Prebieha náborFáza 2/3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06780670A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Mass General Hospital, Boston
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 22. 9. 2026 · NCT07570979A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07114601Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Beth Israel Deaconess Med Center, Boston
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06855277CV CARE: CardioVascular Care in PC Patients
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 22. 9. 2026 · NCT06202820A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Plymouth
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 18. 9. 2026 · NCT06952803A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Beth Israel Deaconess Medical Center ( Site 0043), Boston
- Dana Farber Cancer Institute ( Site 0012), Boston
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 17. 9. 2026 · NCT06925737A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Dana-Farber Cancer Institute, Boston
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 15. 9. 2026 · NCT07581184Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT06040125Serial MRI Scans During Radiation Therapy
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT04188535Prostate Active Surveillance Study
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
Prebieha náborObservačná štúdia
Vek 21 a viac · Muži · Aktualizované 2. 9. 2026 · NCT00756665A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 21. 8. 2026 · NCT06844383Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
- Brigham and Women's Hospital, Boston
Prebieha náborFáza 2
Vek 40 a viac · Muži · Aktualizované 17. 8. 2026 · NCT06957691FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center, Boston
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 14. 8. 2026 · NCT04812366Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Boston
Prebieha náborFáza 1/2
Vek 18 až 130 · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT05417594A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Dana-Farber Cancer Institute, Boston
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 10. 8. 2026 · NCT06067841RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Dana-Farber Cancer Institute at Foxborough, Foxborough
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 30. 7. 2026 · NCT05765500Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
- Dana Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 29. 7. 2026 · NCT05327465PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- Dana-Farber Cancer Institute, Boston
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 22. 7. 2026 · NCT06274047Jump: MR Simulation For Radiation Therapy Master Protocol
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 7. 2026 · NCT04545957Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 2. 7. 2026 · NCT07140900Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Dana Farber Cancer Institute, Boston
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 6. 2026 · NCT04890613Androgen-responsive POSLUMA-guided Intra-prostatic Boost
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford
- a 1 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 29. 5. 2026 · NCT07393867Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.